NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球注射器市場 - 預測(2021年∼2026年)

Global Syringe Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023187
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
全球注射器市場 - 預測(2021年∼2026年) Global Syringe Market - Forecasts from 2021 to 2026
出版日期: 2021年07月12日內容資訊: 英文 112 Pages
簡介

全球注射器市場規模,預計從2019年的67億8,300萬美元到2026年達到91億2,300萬美元,在預期期間以4.33%的年複合成長率發展。

市場的成長可能歸因於需要注射藥物或出於診斷目的從體內提取液體的患者人數不斷增加。此外,在預測期內,人們對各種疫苗接種的認識不斷提高,以及智慧注射器的推出等各種進步,推動了市場的成長。然而,在預測期內,對替代藥物遞送方法(例如貼劑和口服)的日益關注可能會阻礙市場。

本報告提供全球注射器市場調查,市場概要與趨勢,競爭狀態和主要企業的簡介,各類型、各材料、各地區的分析等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供給企業的競爭
    • 買主的競爭
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的競爭關係
  • 產業的價值鏈分析

第5章 各類型:全球注射器市場分析

  • 簡介
  • 胰島素注射器
  • 傳統的注射器
    • 偏心針頭注射器
    • 導管晶片注射器
    • 毛鉤鎖注射器

第6章 各材料:全球注射器市場分析

  • 簡介
  • 玻璃
  • 塑膠
  • 不鏽鋼

第7章 注射器的各尺寸:全球注射器市場分析

  • 簡介
  • 小容量注射器
  • 高容量注射器

第8章 各地區:全球注射器市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 其他
  • 中東和非洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 台灣
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,共同研究
  • 供應商競爭力 矩陣

第10章 企業簡介

  • BD
  • B. Braun Melsungen
  • Terumo
  • Teleflex
  • Nipro
  • Smith's Medical
  • Cardinal Health
  • HMD Healthcare
  • Hamilton Company
  • Advancecare Pharma USA
目錄
Product Code: KSI061611594

The global syringe market is expected to grow at a compound annual growth rate of 4.33% over the forecast period to reach a market size of US$9.123 billion in 2026, from US$6.783 billion in 2019. Syringes are the medical devices used to inject or withdraw fluid from the body. It consists of a hollow cylinder, a plunger, and a needle attached to the cylinder. The downward movement of the plunger results in injecting the fluid into the body, whereas upward movement of the plunger results in withdrawal of the fluid from the body. The syringes were once made from glass and metal and needed to be sterilized before use which has now been replaced by syringes made of plastic and is already pre-sterilized.

The rise in the market may be attributed to the rising patient population base requiring injecting drugs or withdrawal of fluids for diagnostic purposes from the body. Further, rising awareness regarding various vaccinations along with various advancements such as the introduction of smart syringes have led to a boost in the market during the given forecast period. However, growing focus on alternative drug delivery methods such as patches and oral might hamper the market during the given time frame. Major companies have been making significant developments in the market. Furthermore, several regions, globally, have started the procedures to legalize the possessions of syringes for individual use. For instance, in June 2021, New York State Senate announced that they had passed bill 2523, intending to decriminalize possessions and sales of hydroponic syringes. This development is expected to have a positive impact on the global syringe market, in the coming period. Moreover, in June 2021, the state of Arizona in the United States, announced that it had legalized needle or syringe exchange programs, which would allow drug-addicted persons to have a place for free needles. This is development is expected to increase the overall syringe market share, during the forecast period.

Rising prevalence of infectious and chronic diseases.

The market is expected to surge in the coming years, due to the rising prevalence of chronic and infectious diseases, worldwide. Chronic diseases, such as diabetes, cancer, and heart disease, are a major cause of disability and death, worldwide. According to the Centers for Disease Control and Prevention, in the United States, chronic diseases are the leading cause of the nations' US$3.8 trillion, in annual health care costs. According to the International Diabetes Federation's 2019 report, the total number of people living with diabetes, globally, is expected to rise from 463 million in the year 2019 to around 700 million, by the year 2045. The World Health Organization stated that approx. 1.5 million deaths in the year 2019, was caused by diabetes. The increasing rate of cancer is also expected to surge the demand for syringes, worldwide.

According to the data given by the Global Cancer Observatory and the International Agency for the Research on Cancer, an estimated 19.3 million novel cancer cases, approx. 10 million cancer deaths, occurred in the year 2020. Furthermore, the global cancer burden is expected to increase to 28.4 million cases in the year 2040, with a rise of 47%, from the year 2020. There are considerable efforts and initiatives to develop infrastructure for the provision of cancer care and the dissemination of cancer prevention measures for global cancer control. For cancer treatment, IV or intravenous chemo is directly put into a patient's bloodstream through a soft, tiny, plastic tube known as a catheter. The drugs could be given immediately and quickly through a catheter from a syringe, over several minutes. Major companies have been manufacturing syringes for different chronic diseases. BD, one of the largest players in the market, provides conventional syringes, with catheter, eccentric, and luer lock tips for medical purposes. With the increasing prevalence of chronic diseases, the market is expected to register significant growth, during the forecast period.

Impact of COVID-19 Pandemic.

COVID-19 pandemic had been expected to accelerate the demand for syringes, worldwide. Several companies have reported increasing their manufacturing capacity to meet the global demand for syringes. For instance, in March 2021, Hindustan Syringes & Medical Devices announced that they would begin to ship 3.2 million syringes to the UNICEF, in the coming months. The company had also increased its capacity to manufacture 5,900 syringes, per minute. With the introduction of covid vaccines, the global demand for syringes is expected to surge. For instance, Becton, Dickinson, and Company, a U.S based device maker, had announced that it had tallied orders for 2 billion injection devices from countries, worldwide, to accelerate the vaccination rate. The company had delivered over 900 million injection devices, worldwide, and stated that the remaining orders would be delivered by the end of the year 2022. These developments are expected to have a positive impact on the market, in the coming years.

Market Segmentation:

  • By Type
  • Insulin Syringe
  • Conventional Syringe
  • Eccentric Tip Syringe
  • Catheter Tip Syringe
  • Luer Lock Syringe
  • By Material
  • Glass
  • Plastic
  • Stainless Steel
  • By Syringe Size
  • Smaller Volume Syringe
  • Larger Volume Syringe
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Syringe Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Insulin Syringe
  • 5.3. Conventional Syringe
    • 5.3.1. Eccentric Tip Syringe
    • 5.3.2. Catheter Tip Syringe
    • 5.3.3. Luer Lock Syringe

6. Global Syringe Market Analysis, By Material

  • 6.1. Introduction
  • 6.2. Glass
  • 6.3. Plastic
  • 6.4. Stainless Steel

7. Global Syringe Market Analysis, By Syringe Size

  • 7.1. Introduction
  • 7.2. Smaller Volume Syringe
  • 7.3. Larger Volume Syringe

8. Global Syringe Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. France
    • 8.4.3. Germany
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Thailand
    • 8.6.5. Taiwan
    • 8.6.6. Indonesia
    • 8.6.7. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. BD
  • 10.2. B. Braun Melsungen
  • 10.3. Terumo
  • 10.4. Teleflex
  • 10.5. Nipro
  • 10.6. Smith's Medical
  • 10.7. Cardinal Health
  • 10.8. HMD Healthcare
  • 10.9. Hamilton Company
  • 10.10. Advancecare Pharma USA